US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nasus Pharma Ltd.

5.40

-0.0400-0.74%

Volume:3.24K

Turnover:18.51K

Market Cap:48.94M

PE:-25.59

High:6.02

Open:5.80

Low:5.40

Close:5.44

52wk High:9.99

52wk Low:5.40

Shares:9.06M

Float Shares:3.98M

Volume Ratio:0.96

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2110

EPS(LYR):-0.2180

ROE:--

ROA:-106.39%

PB:-11.35

PE(LYR):-24.77

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Nasus Pharma Ltd trading resumes

Amex Halt Add Info Lst 5.520000

THOMSON REUTERS

Nasus Pharma Calls March 5 Special Meeting to Boost Share Capital and Approve New Equity Incentives

Nasus Pharma Shareholders to Vote on U.S. Sub-Plan for 2019 Incentive Option Plan at Upcoming Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NSRX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NSRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NSRX\",,,,,undefined,":{"symbol":"NSRX","market":"US","secType":"STK","nameCN":"Nasus Pharma Ltd.","latestPrice":5.4,"timestamp":1770668205058,"preClose":5.44,"halted":0,"volume":3241,"delay":0,"changeRate":-0.007352941176470594,"floatShares":3982680,"shares":9063458,"eps":-0.211,"marketStatus":"Trading","change":-0.04,"latestTime":"02-09 15:24:17 EST","open":5.8,"high":6.02,"low":5.4,"amount":18513.480034,"amplitude":0.113971,"askPrice":6.55,"askSize":2,"bidPrice":5.09,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.211,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770670800000},"marketStatusCode":2,"adr":0,"listingDate":1755057600000,"exchange":"AMEX","adjPreClose":5.44,"postHourTrading":{"tag":"盘后","latestPrice":5.44,"preClose":5.44,"latestTime":"16:50 EST","volume":15,"amount":81.6,"timestamp":1770414607368,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.959868},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NSRX\",,,,,undefined,":{"symbol":"NSRX","floatShares":3982680,"roa":"-106.39%","roe":"--","lyrEps":-0.217993,"volumeRatio":0.959868,"shares":9063458,"dividePrice":0,"high":6.02,"amplitude":0.113971,"preClose":5.44,"low":5.4,"week52Low":5.4,"pbRate":"-11.35","week52High":9.9899,"institutionHeld":0,"latestPrice":5.4,"committee":0.960784,"eps":-0.211,"divideRate":0,"volume":3241,"delay":0,"ttmEps":-0.211,"open":5.8,"prevYearClose":9.15,"prevWeekClose":5.44,"prevMonthClose":5.74,"prevQuarterClose":9.15,"fiveDayClose":5.502,"twentyDayClose":7.1,"sixtyDayClose":7.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NSRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NSRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NSRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1766120400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NSRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NSRX","date":"2026-02-06","current":-25.781991,"percent":0.958678,"low":-51.389177,"twenty":-47.363077,"median":-44.351994,"eighty":-35.774424,"high":-26.04704,"avg":-41.844468,"sd":6.369751,"marketCap":52545877},"quantilePoints":[{"date":"2025-08-15","current":-47.343663,"twenty":-48.284655,"median":-47.931783,"eighty":-47.578911,"marketCap":72530491},{"date":"2025-08-22","current":-50.265593,"twenty":-50.691372,"median":-49.082873,"eighty":-48.024103,"marketCap":77006889},{"date":"2025-08-29","current":-47.604473,"twenty":-50.029049,"median":-48.047994,"eighty":-47.509856,"marketCap":72930053},{"date":"2025-09-05","current":-47.370886,"twenty":-49.082873,"median":-47.841017,"eighty":-47.486202,"marketCap":72572198},{"date":"2025-09-12","current":-48.136697,"twenty":-48.519903,"median":-47.66361,"eighty":-47.343663,"marketCap":73745420},{"date":"2025-09-19","current":-47.384488,"twenty":-48.195834,"median":-47.722745,"eighty":-47.36793,"marketCap":72593035},{"date":"2025-09-26","current":-47.604473,"twenty":-48.136697,"median":-47.604473,"eighty":-47.343663,"marketCap":72930053},{"date":"2025-10-03","current":-36.900859,"twenty":-48.077561,"median":-47.51577,"eighty":-47.308794,"marketCap":56532116},{"date":"2025-10-10","current":-45.830394,"twenty":-48.047993,"median":-47.384488,"eighty":-45.830394,"marketCap":70212163},{"date":"2025-10-17","current":-46.835706,"twenty":-47.900153,"median":-47.36793,"eighty":-45.534713,"marketCap":71752301},{"date":"2025-10-24","current":-44.943354,"twenty":-47.900153,"median":-47.314116,"eighty":-44.943354,"marketCap":68853218},{"date":"2025-10-31","current":-46.007802,"twenty":-47.900153,"median":-47.308794,"eighty":-45.239034,"marketCap":70483952},{"date":"2025-11-07","current":-44.647674,"twenty":-47.781881,"median":-47.308794,"eighty":-44.943354,"marketCap":68400236},{"date":"2025-11-14","current":-46.717433,"twenty":-47.722745,"median":-47.22009,"eighty":-44.647674,"marketCap":71571108},{"date":"2025-11-21","current":-41.395195,"twenty":-47.722745,"median":-46.835706,"eighty":-44.351994,"marketCap":63417438},{"date":"2025-11-28","current":-41.395195,"twenty":-47.675437,"median":-46.717433,"eighty":-43.654189,"marketCap":63417438},{"date":"2025-12-05","current":-40.508154,"twenty":-47.6163,"median":-46.155642,"eighty":-42.826285,"marketCap":62058492},{"date":"2025-12-12","current":-38.438395,"twenty":-47.604473,"median":-45.830394,"eighty":-41.395195,"marketCap":58887621},{"date":"2025-12-19","current":-37.669627,"twenty":-47.557164,"median":-45.682553,"eighty":-41.383368,"marketCap":57709868},{"date":"2025-12-26","current":-44.351994,"twenty":-47.509856,"median":-45.298465,"eighty":-41.395195,"marketCap":67947255},{"date":"2026-01-02","current":-43.332802,"twenty":-47.445516,"median":-44.987706,"eighty":-41.359713,"marketCap":82895651},{"date":"2026-01-09","current":-33.62436,"twenty":-47.384488,"median":-44.884218,"eighty":-40.236129,"marketCap":64323401},{"date":"2026-01-16","current":-33.62436,"twenty":-47.379047,"median":-44.647674,"eighty":-40.035066,"marketCap":64323401},{"date":"2026-01-23","current":-31.392839,"twenty":-47.370295,"median":-44.529402,"eighty":-38.570149,"marketCap":60054501},{"date":"2026-01-30","current":-26.473264,"twenty":-47.36793,"median":-44.351994,"eighty":-37.823381,"marketCap":50643354},{"date":"2026-02-06","current":-27.467787,"twenty":-47.363077,"median":-44.351994,"eighty":-35.774424,"marketCap":52545877}],"updateTime":1770633692846},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NSRX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608078608","title":"Nasus Pharma Ltd trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2608078608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608078608?lang=en_us&edition=fundamental","pubTime":"2026-02-04 04:00","pubTimestamp":1770148815,"startTime":"0","endTime":"0","summary":"14:59 EST Nasus Pharma (NSRX) Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nasus-pharma-ltd-trading-resumes-thefly-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nasus-pharma-ltd-trading-resumes-thefly-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NSRX"],"gpt_icon":0},{"id":"2608680224","title":"Amex Halt  Add Info Lst 5.520000","url":"https://stock-news.laohu8.com/highlight/detail?id=2608680224","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608680224?lang=en_us&edition=fundamental","pubTime":"2026-02-04 03:49","pubTimestamp":1770148157,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nAQN2LKIUG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NSRX","BK4007"],"gpt_icon":0},{"id":"2607054913","title":"Nasus Pharma Calls March 5 Special Meeting to Boost Share Capital and Approve New Equity Incentives","url":"https://stock-news.laohu8.com/highlight/detail?id=2607054913","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607054913?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:50","pubTimestamp":1769723441,"startTime":"0","endTime":"0","summary":"Nasus Pharma Ltd. ( ($NSRX) ) has issued an update. On January 29, 2026, Nasus Pharma Ltd. filed a report announcing it will hold a Special General...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nasus-pharma-calls-march-5-special-meeting-to-boost-share-capital-and-approve-new-equity-incentives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nasus-pharma-calls-march-5-special-meeting-to-boost-share-capital-and-approve-new-equity-incentives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","NSRX","BK4585","EQR","BK4007","BK4588"],"gpt_icon":0},{"id":"2607059120","title":"Nasus Pharma Shareholders to Vote on U.S. Sub-Plan for 2019 Incentive Option Plan at Upcoming Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2607059120","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607059120?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:17","pubTimestamp":1769721461,"startTime":"0","endTime":"0","summary":"Nasus Pharma Ltd. has scheduled a Special General Meeting of Shareholders for March 5, 2026, where shareholders will vote on a proposal to approve the Sub-Plan for U.S. Persons to the Company's 2019 Incentive Option Plan. The board of directors recommends voting in favor of this proposal. Only shareholders of record as of February 9, 2026, are eligible to vote at the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nasus Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL1KVNBP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NSRX"],"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NSRX\",params:#limit:6,delay:false,,,undefined,":[]}}